Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 3/20 | 0.47 |
| ▸ | RARB | P10826 | 1/20 | 0.44 |
| ▸ | RARG | P13631 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.42 |
| ▸ | RXRA | P19793 | 4/20 | 0.41 |
| ▸ | RXRB | P28702 | 4/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | RXRG | P48443 | 2/20 | 0.40 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18275126 | 0.83 | MEN1 (0.53) | SRD5A2RARBRARGMEN1CYP1A2 | |
| SCHEMBL18275124 | 0.80 | NR1I2 (0.49) | SRD5A2RARBRARGMEN1CYP1A2 | |
| SCHEMBL18275080 | 0.79 | SRD5A2 (0.46) | SRD5A2RARBRARGMEN1CYP1A2 | |
| SCHEMBL18275128 | 0.78 | SRD5A2 (0.45) | SRD5A2RARBMEN1CYP1A2KMT2A | |
| SCHEMBL18151473 | 0.77 | AR (0.43) | EPHX2ARNR1H3ALDH1A1 | |
| SCHEMBL448814 | 0.77 | SHBG (0.59) | SRD5A2RARBRARGMEN1CYP1A2 | |
| SCHEMBL2879876 | 0.77 | SRD5A2 (0.55) | SRD5A2RARBRARGEPHX2NR1H4 | |
| SCHEMBL1021804 | 0.77 | SRD5A2 (0.55) | SRD5A2RARBRARGEPHX2NR1H4 | |
| SCHEMBL18275085 | 0.76 | SRD5A2 (0.44) | SRD5A2RARBRARGMEN1CYP1A2 | |
| SCHEMBL18275129 | 0.75 | PTPN1 (0.48) | SRD5A2CYP1A2RXRARXRBNR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108430974-B | ROR gamma modulators | 领先制药控股公司 | 2021-09-17 | — | — | CN | disclosed |
| US-10556866-B2 | ROR gamma (RORγ) modulators | LEAD PHARMA HOLDING B.V. (NL) | 2020-02-11 | — | — | US | disclosed |
| US-10556866-B2 | ROR gamma (RORγ) modulators | LEAD PHARMA HOLDING B.V. (NL) | 2020-02-11 | — | — | US | disclosed |
| EP-3303293-B1 | ROR-GAMMA MODULATORS | LEAD PHARMA B V (NL) | 2020-02-05 | — | — | EP | disclosed |
| EP-3303293-B1 | ROR-GAMMA MODULATORS | LEAD PHARMA B V (NL) | 2020-02-05 | — | — | EP | disclosed |
| US-20180162815-A1 | ROR GAMMA (RORY) MODULATORS | LEAD PHARMA HOLDING B.V. (NL) | 2018-06-14 | — | — | US | disclosed |
| US-20180162815-A1 | ROR GAMMA (RORY) MODULATORS | LEAD PHARMA HOLDING B.V. (NL) | 2018-06-14 | — | — | US | disclosed |
| US-20180162815-A1 | ROR GAMMA (RORY) MODULATORS | LEAD PHARMA HOLDING B.V. (NL) | 2018-06-14 | — | — | US | disclosed |
| WO-2016193461-A1 | ROR GAMMA (RORγ) MODULATORS | LEAD PHARMA CEL MODELS IP B.V. (NL) | 2016-12-08 | — | — | WO | disclosed |
| EP-3101009-A1 | ROR GAMMA (RORY) MODULATORS | Lead Pharma Cel Models IP B.V. (NL) | 2016-12-07 | — | — | EP | disclosed |
| EP-3101009-A1 | ROR GAMMA (RORY) MODULATORS | Lead Pharma Cel Models IP B.V. (NL) | 2016-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180162815-A1 | ROR GAMMA (RORY) MODULATORS | RORC, RORA, RORB | SRD5A2 1091/4885RARB 9/4885RARG 14/4885 |
| US-10556866-B2 | ROR gamma (RORγ) modulators | RORC, RORA, RORB | SRD5A2 708/4885RARB 27/4885RARG 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.